BOOK
Imaging of Select Multisystem Disorders, An issue of Radiologic Clinics of North America, E-Book
(2016)
Additional Information
Book Details
Abstract
This issue of Radiologic Clinics of North America focuses on Imaging of Selected Multi-System Disorders. Articles will include: von Hippel-Lindau syndrome: Review of Genetics and Imaging; Cross-sectional Imaging Review of Tuberous Sclerosis; Multiple Endocrine Neoplasia Syndromes: A Comprehensive Imaging Review; Imaging Manifestations of Thoracic Tuberculosis; Imaging Spectrum of Extra-Thoracic Tuberculosis; MDCT and MRI Findings of Mycotic Infections; Imaging of Sarcoidosis: A Contemporary Review; Imaging of Inflammatory Myofibroblastic Tumor; Recent Advances in Imaging of IgG4-related Disease; Systemic Vasculopathy Syndromes: Overview of Imaging & Management; Taxonomy and Imaging Manifestations of Systemic Amyloidosis; State of the Art Imaging & Staging of Multiple Myeloma & Plasmacytoma; Solitary Fibrous Tumor: 2016 Imaging Update; and more!
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Imaging of Select Multisystem Disorders\r | i | ||
| Copyright\r | ii | ||
| Contributors | iii | ||
| CONSULTING EDITOR | iii | ||
| EDITOR | iii | ||
| AUTHORS | iii | ||
| Contents | vii | ||
| Preface: Imaging of Select Multisystem Disorders\r | vii | ||
| Erratum\r | vii | ||
| von Hippel-Lindau Disease: Review of Genetics and Imaging\r | vii | ||
| Cross-sectional Imaging Review of Tuberous Sclerosis\r | vii | ||
| Multiple Endocrine Neoplasia Syndromes: A Comprehensive Imaging Review\r | vii | ||
| Imaging Manifestations of Thoracic Tuberculosis\r | vii | ||
| Imaging Spectrum of Extrathoracic Tuberculosis\r | viii | ||
| Multidetector Computed Tomography and MR Imaging Findings in Mycotic Infections\r | viii | ||
| Imaging of Sarcoidosis: A Contemporary Review\r | viii | ||
| Immunoglobulin G4–Related Disease: Recent Advances in Pathogenesis and Imaging Findings\r | viii | ||
| Inflammatory Myofibroblastic Tumors: Current Update\r | ix | ||
| Solitary Fibrous Tumors: 2016 Imaging Update\r | ix | ||
| State-of-the-Art Imaging and Staging of Plasma Cell Dyscrasias\r | ix | ||
| Taxonomy and Imaging Manifestations of Systemic Amyloidosis\r | ix | ||
| Systemic Vasculopathies: Imaging and Management\r | x | ||
| CME Accreditation Page\r | xi | ||
| PROGRAM OBJECTIVE | xi | ||
| TARGET AUDIENCE | xi | ||
| LEARNING OBJECTIVES | xi | ||
| ACCREDITATION | xi | ||
| DISCLOSURE OF CONFLICTS OF INTEREST | xi | ||
| UNAPPROVED/OFF-LABEL USE DISCLOSURE | xi | ||
| TO ENROLL | xi | ||
| METHOD OF PARTICIPATION | xii | ||
| CME INQUIRIES/SPECIAL NEEDS | xii | ||
| RADIOLOGIC CLINICS OF NORTH AMERICA\r | xiii | ||
| FORTHCOMING ISSUES | xiii | ||
| July 2016 | xiii | ||
| September 2016 | xiii | ||
| November 2016 | xiii | ||
| RECENT ISSUES | xiii | ||
| March 2016 | xiii | ||
| January 2016 | xiii | ||
| November 2015 | xiii | ||
| Preface: Imaging of Select Multisystem Disorders\r | xv | ||
| Erratum | xvii | ||
| von Hippel-Lindau Disease | 409 | ||
| Key points | 409 | ||
| INTRODUCTION | 409 | ||
| GENETICS AND PATHOLOGY | 410 | ||
| Central Nervous System Manifestations | 411 | ||
| RETINAL HEMANGIOBLASTOMAS | 411 | ||
| CENTRAL NERVOUS SYSTEM HEMANGIOBLASTOMAS | 411 | ||
| ENDOLYMPHATIC SAC TUMOR | 413 | ||
| Abdominal Manifestations | 414 | ||
| Pancreas | 414 | ||
| Kidney | 415 | ||
| Adrenal pheochromocytoma | 416 | ||
| Reproductive organs | 418 | ||
| REFERENCES | 419 | ||
| Cross-sectional Imaging Review of Tuberous Sclerosis | 423 | ||
| Key points | 423 | ||
| INTRODUCTION | 423 | ||
| CAUSE AND GENETICS | 424 | ||
| REVISED DIAGNOSTIC CRITERIA | 424 | ||
| NEUROLOGIC MANIFESTATIONS OF TUBEROUS SCLEROSIS COMPLEX | 424 | ||
| IMAGING TECHNIQUES | 424 | ||
| NEUROPATHOLOGICAL MANIFESTATIONS OF TUBEROUS SCLEROSIS | 425 | ||
| Cerebral Tubers | 425 | ||
| Cerebellar Tubers | 427 | ||
| Radial Migration Lines | 428 | ||
| Subependymal Nodules | 429 | ||
| Subependymal Giant Cell Astrocytoma | 430 | ||
| Subependymal nodule versus subependymal giant cell astrocytoma | 431 | ||
| Other Less Common Associations with Tuberous Sclerosis Complex | 431 | ||
| Hemimegalencephaly | 431 | ||
| Aneurysms | 432 | ||
| Chordomas | 432 | ||
| ABDOMINAL MANIFESTATIONS | 433 | ||
| Renal Manifestations | 433 | ||
| Angiomyolipomas | 433 | ||
| Renal Cysts | 435 | ||
| Renal Cell Carcinoma | 435 | ||
| Other Abdominal Manifestations | 435 | ||
| CARDIOTHORACIC MANIFESTATIONS | 435 | ||
| Cardiac Manifestations | 435 | ||
| Thoracic Manifestations | 436 | ||
| Lymphangioleiomyomatosis | 436 | ||
| Multifocal Micronodular Pneumocyte Hyperplasia | 436 | ||
| SURVEILLANCE AND MONITORING OF PATIENTS WITH TUBEROUS SCLEROSIS COMPLEX | 437 | ||
| At Initial Diagnosis | 437 | ||
| Follow-up Recommendations | 437 | ||
| TREATMENT | 437 | ||
| SUMMARY | 437 | ||
| REFERENCES | 438 | ||
| Multiple Endocrine Neoplasia Syndromes | 441 | ||
| Key points | 441 | ||
| INTRODUCTION | 441 | ||
| MEN1 SYNDROME | 441 | ||
| MEN1 Tumors | 442 | ||
| Parathyroid tumors | 442 | ||
| Pancreatic neuroendocrine tumors | 442 | ||
| Pituitary tumors | 444 | ||
| Adrenal cortical tumors | 445 | ||
| Other neuroendocrine tumors | 446 | ||
| MEN2 SYNDROME | 446 | ||
| MEN2 Tumors | 447 | ||
| Medullary thyroid carcinoma | 447 | ||
| Pheochromocytoma | 447 | ||
| Parathyroid tumors | 449 | ||
| MEN4 SYNDROME | 449 | ||
| MEN4 Tumors | 450 | ||
| Parathyroid tumors | 450 | ||
| Pituitary tumors | 450 | ||
| SUMMARY | 450 | ||
| REFERENCES | 450 | ||
| Imaging Manifestations of Thoracic Tuberculosis | 453 | ||
| Key points | 453 | ||
| INTRODUCTION | 453 | ||
| PATHOPHYSIOLOGY | 454 | ||
| TRADITIONAL VERSUS NEW CONCEPT OF ETIOPATHOGENESIS AND IMAGING MANIFESTATIONS OF TUBERCULOSIS | 454 | ||
| PRIMARY TUBERCULOSIS | 455 | ||
| REACTIVATION (POSTPRIMARY) TUBERCULOSIS: IMAGING FEATURES IN IMMUNOCOMPETENT HOSTS | 456 | ||
| TUBERCULOSIS WITH HUMAN IMMUNODEFICIENCY VIRUS COINFECTION | 460 | ||
| HIGHLY ACTIVE ANTIRETROVIRAL THERAPY AND IMMUNE RESTORATION SYNDROME | 460 | ||
| MILIARY TUBERCULOSIS | 461 | ||
| MULTIDRUG-RESISTANT TUBERCULOSIS AND EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS | 461 | ||
| COMPLICATIONS AND SPECIAL FORMS | 463 | ||
| Tracheobronchial Tuberculosis | 463 | ||
| Bronchopleural Fistula | 463 | ||
| Rasmussen Aneurysm | 464 | ||
| Mycetoma | 465 | ||
| Empyema Necessitatis | 465 | ||
| Chest Wall Tuberculosis | 466 | ||
| Spinal Tuberculosis | 467 | ||
| Collapse Therapy | 467 | ||
| Cardiovascular Tuberculosis | 468 | ||
| SUMMARY | 470 | ||
| REFERENCES | 470 | ||
| Imaging Spectrum of Extrathoracic Tuberculosis | 475 | ||
| Key points | 475 | ||
| INTRODUCTION | 475 | ||
| CENTRAL NERVOUS SYSTEM TUBERCULOSIS | 476 | ||
| Pathophysiology | 476 | ||
| TUBERCULOUS MENINGITIS | 476 | ||
| TUBERCULOUS PACHYMENINGITIS | 476 | ||
| COMPLICATIONS OF TUBERCULOUS MENINGITIS | 477 | ||
| Hydrocephalus | 477 | ||
| Vasculitis | 477 | ||
| Cranial Nerve Involvement | 478 | ||
| TUBERCULOMA | 478 | ||
| TUBERCULOUS BRAIN ABSCESS | 479 | ||
| TUBERCULOUS CEREBRITIS | 480 | ||
| TUBERCULOUS ENCEPHALOPATHY | 480 | ||
| SPINAL CORD AND MENINGEAL INVOLVEMENT | 481 | ||
| TUBERCULOUS LYMPHADENITIS | 481 | ||
| ABDOMINAL TUBERCULOSIS | 481 | ||
| Abdominal Lymphadenopathy | 481 | ||
| Peritoneal Tuberculosis | 482 | ||
| Wet ascitic type | 482 | ||
| Fibrotic fixed type | 482 | ||
| Dry or 'plastic' type | 483 | ||
| Gastrointestinal Tract Tuberculosis | 483 | ||
| Esophageal tuberculosis | 483 | ||
| Gastroduodenal tuberculosis | 483 | ||
| Ileocecal tuberculosis | 483 | ||
| Colonic tuberculosis | 484 | ||
| Plain radiography | 484 | ||
| Barium studies | 484 | ||
| Computed tomography scan | 485 | ||
| Hepatosplenic Tuberculosis | 486 | ||
| Adrenal Tuberculosis | 486 | ||
| Genitourinary Tuberculosis | 486 | ||
| Pathophysiology | 487 | ||
| Plain radiography | 487 | ||
| Intravenous urography | 487 | ||
| Computed tomography | 488 | ||
| MR imaging | 489 | ||
| Genital Tuberculosis | 489 | ||
| MUSCULOSKELETAL TUBERCULOSIS | 489 | ||
| Pathogenesis | 489 | ||
| Tuberculous Spondylitis | 490 | ||
| Plain radiographs | 490 | ||
| Ultrasonography | 490 | ||
| Computed tomography scan | 490 | ||
| MR imaging | 490 | ||
| Tuberculous Arthritis | 491 | ||
| Plain radiographs and computed tomography scan | 492 | ||
| Ultrasonography | 492 | ||
| MR imaging | 493 | ||
| Tuberculous Osteomyelitis | 495 | ||
| Plain radiographs and computed tomography scan | 495 | ||
| Ultrasonography | 496 | ||
| MR imaging | 496 | ||
| Tuberculous Dactylitis | 496 | ||
| Calvarial Tuberculosis | 497 | ||
| Soft Tissue Tuberculosis | 498 | ||
| SUMMARY | 498 | ||
| ACKNOWLEDGMENTS | 498 | ||
| REFERENCES | 498 | ||
| Multidetector Computed Tomography and MR Imaging Findings in Mycotic Infections | 503 | ||
| Key points | 503 | ||
| INTRODUCTION | 503 | ||
| CENTRAL NERVOUS SYSTEM INFECTION | 503 | ||
| Aspergillosis | 504 | ||
| Hematogenous Spread | 504 | ||
| Rhinocerebral Spread | 504 | ||
| Cryptococcosis | 505 | ||
| Mucormycosis | 505 | ||
| IMAGING | 506 | ||
| Candidiasis | 506 | ||
| Blastomycosis | 507 | ||
| HEAD AND NECK | 507 | ||
| Acute Invasive Sinusitis | 507 | ||
| Chronic Invasive Sinusitis | 507 | ||
| Chronic Granulomatous Fungal Sinusitis | 507 | ||
| Noninvasive Fungal Sinusitis | 507 | ||
| PULMONARY FUNGAL INFECTION | 508 | ||
| Aspergillosis | 508 | ||
| Saprophytic aspergillosis (aspergilloma) | 508 | ||
| Hypersensitivity reaction (allergic bronchopulmonary aspergillosis) | 508 | ||
| Semi-invasive (chronic necrotizing) aspergillosis | 508 | ||
| Airway-invasive aspergillosis | 509 | ||
| Angioinvasive aspergillosis | 509 | ||
| Pneumocystis jiroveci (Pneumocystis carinii) | 510 | ||
| Zygomycosis | 510 | ||
| Cryptococcosis | 510 | ||
| Histoplasmosis | 511 | ||
| Candidiasis | 511 | ||
| Coccidioidomycosis | 511 | ||
| North American Blastomycosis | 511 | ||
| South American Blastomycosis | 511 | ||
| INTRA-ABDOMINAL FUNGAL INFECTIONS | 511 | ||
| Liver and Spleen | 512 | ||
| Biliary System | 512 | ||
| Pancreas | 513 | ||
| Adrenal Glands | 513 | ||
| Urogenital Tract | 514 | ||
| Renal Aspergillosis | 514 | ||
| Renal Pneumocystis jiroveci Infection | 515 | ||
| Renal Mucormycosis | 515 | ||
| Fungal Cystitis and Prostatitis | 515 | ||
| Gastrointestinal Tract | 515 | ||
| Peritonitis | 515 | ||
| MUSCULOSKELETAL | 515 | ||
| SUMMARY | 516 | ||
| REFERENCES | 516 | ||
| Imaging of Sarcoidosis | 519 | ||
| Key points | 519 | ||
| INTRODUCTION | 519 | ||
| CARDIOTHORACIC SYSTEM | 520 | ||
| Lungs | 520 | ||
| Clinical manifestations | 520 | ||
| Imaging features | 520 | ||
| Mediastinal adenopathy | 521 | ||
| Pulmonary vasculature | 522 | ||
| Cardiac | 522 | ||
| Clinical manifestations | 522 | ||
| Imaging features | 522 | ||
| Magnetic resonance imaging | 522 | ||
| Nuclear medicine | 522 | ||
| Breast | 523 | ||
| Clinical manifestations | 523 | ||
| Imaging features | 523 | ||
| ABDOMINAL ORGANS | 524 | ||
| Liver and Spleen | 524 | ||
| Immunoglobulin G4–Related Disease: Recent Advances in Pathogenesis and Imaging Findings | 535 | ||
| Key points | 535 | ||
| INTRODUCTION | 535 | ||
| EPIDEMIOLOGY AND CLINICAL FEATURES | 536 | ||
| CURRENT CONCEPTS IN PATHOGENESIS | 537 | ||
| DIAGNOSIS | 537 | ||
| ROLE OF IMAGING | 538 | ||
| HEAD, NECK, AND INTRACRANIAL DISEASE | 539 | ||
| Orbits | 539 | ||
| Salivary Glands | 539 | ||
| Thyroid | 540 | ||
| Intracranial Disease | 540 | ||
| THORAX | 541 | ||
| Lung Parenchymal, Airway, and Pleural Disease | 541 | ||
| Mediastinal Disease | 541 | ||
| Cardiovascular Disease | 543 | ||
| ABDOMEN AND PELVIS | 544 | ||
| Pancreas | 544 | ||
| Hepatobiliary System | 545 | ||
| Retroperitoneal Fibrosis | 546 | ||
| Kidney | 546 | ||
| Sclerosing Mesenteritis | 547 | ||
| Gastrointestinal Tract | 547 | ||
| Prostate | 547 | ||
| MANAGEMENT | 547 | ||
| SUMMARY | 549 | ||
| REFERENCES | 549 | ||
| Inflammatory Myofibroblastic Tumors | 553 | ||
| Key points | 553 | ||
| INTRODUCTION | 553 | ||
| EPIDEMIOLOGY, ETIOPATHOGENESIS, AND CLINICAL MANIFESTATIONS | 554 | ||
| IMAGING FEATURES OF INFLAMMATORY MYOFIBROBLASTIC TUMOR | 554 | ||
| Inflammatory Myofibroblastic Tumor of the Lung | 554 | ||
| Tracheobronchial Inflammatory Myofibroblastic Tumor | 555 | ||
| Mediastinal Inflammatory Myofibroblastic Tumor | 555 | ||
| Cardiac Inflammatory Myofibroblastic Tumor | 555 | ||
| Inflammatory Myofibroblastic Tumor of the Hepatobiliary System | 555 | ||
| Pancreatic Inflammatory Myofibroblastic Tumor | 556 | ||
| Gastrointestinal Tract Inflammatory Myofibroblastic Tumor | 557 | ||
| Mesenteric Inflammatory Myofibroblastic Tumor | 558 | ||
| Retroperitoneal Inflammatory Myofibroblastic Tumor | 558 | ||
| Renal Inflammatory Myofibroblastic Tumor | 558 | ||
| Urinary Bladder Inflammatory Myofibroblastic Tumor | 560 | ||
| Inflammatory Myofibroblastic Tumor in the Head and Neck, Central Nervous System, and Bone | 561 | ||
| SUMMARY | 562 | ||
| REFERENCES | 562 | ||
| Solitary Fibrous Tumors | 565 | ||
| Key points | 565 | ||
| INTRODUCTION | 565 | ||
| EPIDEMIOLOGY, PATHOLOGY, AND REVISED WORLD HEALTH ORGANIZATION CLASSIFICATION | 566 | ||
| IMMUNOHISTOCHEMICAL ANALYSIS | 567 | ||
| SOLITARY FIBROUS TUMORS BY LOCATION | 567 | ||
| Head and Neck Solitary Fibrous Tumors | 567 | ||
| Intracranial solitary fibrous tumors | 567 | ||
| Extracranial solitary fibrous tumors | 568 | ||
| Thoracic solitary fibrous tumors | 569 | ||
| Abdominal and Pelvic Solitary Fibrous Tumors | 572 | ||
| Hepatic solitary fibrous tumors | 572 | ||
| Renal and retroperitoneal solitary fibrous tumor | 573 | ||
| Pelvic solitary fibrous tumors | 574 | ||
| Solitary Fibrous Tumors of the Soft Tissues | 574 | ||
| Metastatic Disease | 574 | ||
| MANAGEMENT OF SOLITARY FIBROUS TUMOR: ROLE OF SYSTEMIC THERAPY | 574 | ||
| SUMMARY | 577 | ||
| REFERENCES | 577 | ||
| State-of-the-Art Imaging and Staging of Plasma Cell Dyscrasias | 581 | ||
| Key points | 581 | ||
| INTRODUCTION | 581 | ||
| MONOCLONAL GAMMOPATHY OF UNKNOWN SIGNIFICANCE | 582 | ||
| ASYMPTOMATIC SMOLDERING MYELOMA | 583 | ||
| SOLITARY PLASMACYTOMA | 584 | ||
| Solitary Plasmacytoma of the Bone | 584 | ||
| Solitary Extramedullary Plasmacytoma | 584 | ||
| MULTIPLE MYELOMA (SYMPTOMATIC MULTIPLE MYELOMA) | 586 | ||
| EXTRAOSSEOUS AND EXTRAMEDULLARY MANIFESTATIONS OF MYELOMA | 589 | ||
| Nonsecretory Myeloma | 590 | ||
| Oligosecretory Myeloma | 590 | ||
| POLYNEUROPATHY, ORGANOMEGALY, ENDOCRINOPATHY, MONOCLONAL PROTEIN, AND SKIN CHANGES SYNDROME | 591 | ||
| OTHER | 592 | ||
| Waldenström Macroglobulinema | 592 | ||
| Amyloidosis and Monoclonal Immunoglobulin Deposition Diseases | 594 | ||
| Light Chain Deposition Disease and Heavy Chain Deposition Disease | 594 | ||
| REFERENCES | 594 | ||
| Taxonomy and Imaging Manifestations of Systemic Amyloidosis | 597 | ||
| Key points | 597 | ||
| INTRODUCTION | 597 | ||
| AMYLOID TYPES AND MANAGEMENT | 597 | ||
| GENERAL IMAGING FEATURES OF AMYLOID DEPOSITION | 598 | ||
| HEART | 598 | ||
| Amyloid Variants Affecting the Heart | 598 | ||
| Clinical Features and Pathophysiology | 599 | ||
| Laboratory and Electrocardiographic Findings | 599 | ||
| Prognosis | 599 | ||
| Echocardiography | 599 | ||
| MR Imaging | 600 | ||
| Nuclear Medicine | 601 | ||
| Computed Tomography | 601 | ||
| THORAX | 603 | ||
| Tracheobronchial Amyloidosis | 603 | ||
| Parenchymal Amyloidosis | 603 | ||
| Mediastinal or Hilar Adenopathy | 604 | ||
| GASTROINTESTINAL AND GENITOURINARY TRACTS | 604 | ||
| Liver | 605 | ||
| Spleen | 605 | ||
| Gastrointestinal Tract | 605 | ||
| Kidney | 606 | ||
| Urinary Bladder | 606 | ||
| Ureter and Renal Pelvis | 606 | ||
| Urethra | 606 | ||
| Seminal Vesicle | 607 | ||
| Retroperitoneum and Mesentery | 607 | ||
| MUSCULOSKELETAL SYSTEM | 607 | ||
| Amyloid Arthropathy | 608 | ||
| Amyloidoma | 608 | ||
| Amyloid Myopathy | 609 | ||
| Peripheral Nerve Amyloid | 609 | ||
| REFERENCES | 610 | ||
| Systemic Vasculopathies | 613 | ||
| Key points | 613 | ||
| INTRODUCTION | 613 | ||
| LARGE-VESSEL VASCULITIS | 613 | ||
| Takayasu Arteritis | 613 | ||
| Giant Cell Arteritis | 616 | ||
| MEDIUM-VESSEL VASCULITIS | 617 | ||
| Polyarteritis Nodosa | 617 | ||
| Kawasaki Disease (Mucocutaneous Lymph Node Syndrome) | 618 | ||
| SMALL-VESSEL VASCULITIS | 619 | ||
| Antineutrophil Cytoplasmic Antibody–Associated Vasculitis | 619 | ||
| VARIABLE-VESSEL VASCULITIS | 619 | ||
| Behçet Disease | 619 | ||
| VASCULITIS ASSOCIATED WITH SYSTEMIC DISEASE | 620 | ||
| Rheumatoid and Seronegative Arthritis–Associated Vasculitis | 620 | ||
| Systemic Lupus Erythematosus | 620 | ||
| VASCULITIS ASSOCIATED WITH PROBABLE ETIOLOGY | 621 | ||
| Thromboangiitis Obliterans (Buerger’s Disease) | 621 | ||
| Drug-Induced Vasculitis | 621 | ||
| VASCULOPATHY ASSOCIATED WITH CONNECTIVE TISSUE DISORDERS | 622 | ||
| Marfan Syndrome | 622 | ||
| Loeys-Dietz Syndrome | 622 | ||
| Ehlers-Danlos Syndrome | 623 | ||
| MISCELLANEOUS VASCULOPATHIES | 623 | ||
| Fibromuscular Dysplasia | 623 | ||
| Segmental Arterial Mediolysis | 625 | ||
| SUMMARY | 626 | ||
| ACKNOWLEDGMENTS | 626 | ||
| REFERENCES | 626 | ||
| Index | 629 |